Stewart McNaull | Senior VP, Business Development
KBI Biopharma

Stewart McNaull, Senior VP, Business Development, KBI Biopharma

Stewart has nearly 20 years of experience in biopharmaceutical process development and manufacturing with a focus towards driving technology innovation to the manufacturing floor.  He has led upstream process development and cGMP manufacturing groups, managing clinical and commercial program supply.  Stewart has been a leader in the evaluation of single-use technologies and has played a key role in the design and implementation of five cGMP single-use manufacturing streams globally.  He has designed several innovation initiatives, including development of new technical offerings for sales and marketing launch.  Stewart maintains a strong industry presence by presenting at major conferences and as a steering committee member of the BPOG industry consortium for Technology Roadmapping.  His previous experience includes technical roles at Bayer Biologics, followed by 15 years of biopharma CDMO technical and management experience.  Stewart earned his Ph.D. in Chemical Engineering/Bioengineering at Georgia Institute of Technology.

Appearances:



EAC 2017 Day 2, Wednesday 1st November 2017 @ 15:35

The road to the clinic – a CDMO perspective

  • How early is early enough – considerations for cell line development
  • Titers vs. Critical Quality Attributes – are high titers really better?
  • Developability and the need to develop a robust process that will transfer into manufacturing
  • Analytics, Analytics, Analytics
 

back to speakers